Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Azactam, aztreonam
print preview
bookmark
share with colleague
General Information
Company
Bristol-Myers Squibb Co.
Description
IV formulation of aztreonam
Molecular Target
Mechanism of Action
Latest Stage of Development
Marketed
Indication
Gram-negative bacterial infection
Partner
Elan Corp. plc
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy